BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2173749)

  • 1. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
    Fretland DJ; Widomski D; Tsai BS; Zemaitis JM; Levin S; Djuric SW; Shone RL; Gaginella TS
    J Pharmacol Exp Ther; 1990 Nov; 255(2):572-6. PubMed ID: 2173749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical isomers of a leukotriene B4 antagonist have differential effects on granulocyte diapedesis in the guinea pig dermis.
    Fretland DJ; Widomski DL; Anglin CP; Yu S; Djuric SW
    Chirality; 1992; 4(6):353-5. PubMed ID: 1333259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of leukotriene-B4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation.
    Fretland DJ; Levin S; Tsai BS; Djurić SW; Widomski DL; Zemaitis JM; Shone RL; Bauer RF
    Agents Actions; 1989 Jun; 27(3-4):395-7. PubMed ID: 2552769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Effect of second-generation leukotriene B4 receptor antagonists, SC-50605 and SC-51146.
    Fretland DJ; Widomski DL; Anglin CP; Penning TD; Yu S; Djuric SW
    Inflammation; 1993 Jun; 17(3):353-60. PubMed ID: 8392493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: impact upon leukotriene B4- and 12(R)-HETE-mediated events.
    Fretland DJ; Anglin CP; Bremer M; Isakson P; Widomski DL; Paulson SK; Docter SH; Djuric SW; Penning TD; Yu S
    Inflammation; 1995 Apr; 19(2):193-205. PubMed ID: 7601505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activity of the second generation leukotriene B4 receptor antagonist, SC-53228: effects on acute colonic inflammation and hepatic function in rodents.
    Fretland DJ; Anglin CP; Widomski D; Baron DA; Maziasz T; Smith PF
    Inflammation; 1995 Oct; 19(5):503-15. PubMed ID: 8543366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8- propyl-2H-1-benzopyran-2-carboxylic acid: an orally active selective leukotriene B4 receptor antagonist.
    Djuric SW; Collins PW; Jones PH; Shone RL; Tsai BS; Fretland DJ; Butchko GM; Villani-Price D; Keith RH; Zemaitis JM
    J Med Chem; 1989 Jun; 32(6):1145-7. PubMed ID: 2542550
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis.
    Fretland DJ; Widomski DL; Zemaitis JM; Djurić SW; Shone RL
    Inflammation; 1989 Oct; 13(5):601-5. PubMed ID: 2553605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte infiltration in experimental colitis in the rat is interleukin-1 dependent and leukotriene independent.
    McCafferty DM; Rioux KJ; Wallace JL
    Eicosanoids; 1992; 5(3-4):121-5. PubMed ID: 1337973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation of guinea pig dermis. Effects of leukotriene B4 receptor antagonist, SC-41930.
    Fretland DJ; Widomski DL; Zemaitis JM; Walsh RE; Levin S; Djuric SW; Shone RL; Tsai BS; Gaginella TS
    Inflammation; 1990 Dec; 14(6):727-39. PubMed ID: 1965311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotriene B4: an inflammatory mediator with vascular actions in vivo.
    Bray MA
    Agents Actions Suppl; 1982; 11():51-61. PubMed ID: 6295113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
    Villani-Price D; Yang DC; Walsh RE; Fretland DJ; Keith RH; Kocan G; Kachur JF; Gaginella TS; Tsai BS
    J Pharmacol Exp Ther; 1992 Jan; 260(1):187-91. PubMed ID: 1309871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiinflammatory agent SC-41930 inhibits granulocyte infiltration of the rodent dermis induced by 6-trans-leukotriene B4.
    Fretland DJ; Widomski DL; Anglin CP; Gaginella TS
    Prostaglandins Leukot Essent Fatty Acids; 1991 Sep; 44(1):61-5. PubMed ID: 1658813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The design and synthesis of second generation leukotriene B4 (LTB4) receptor antagonists related to SC-41930.
    Penning TD; Djuric SW; Docter SH; Yu SS; Spangler D; Anglin CP; Fretland DJ; Kachur JF; Keith RH; Tsai BS
    Agents Actions; 1993; 39 Spec No():C11-3. PubMed ID: 8273545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
    Rao TS; Yu SS; Djuric SW; Isakson PC
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ONO-LB-457: a novel and orally active leukotriene B4 receptor antagonist.
    Kishikawa K; Matsunaga N; Maruyama T; Seo R; Toda M; Miyamoto T; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():407-10. PubMed ID: 1847777
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo characterization of zymosan-induced mouse peritoneal inflammation.
    Rao TS; Currie JL; Shaffer AF; Isakson PC
    J Pharmacol Exp Ther; 1994 Jun; 269(3):917-25. PubMed ID: 8014878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermal inflammation in primates, mice, and guinea pigs: attenuation by second-generation leukotriene B4 receptor antagonist, SC-53228.
    Fretland DJ; Gokhale R; Mathur L; Baron DA; Paulson SK; Stolzenbach J
    Inflammation; 1995 Jun; 19(3):333-46. PubMed ID: 7628862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
    Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells.
    Kemény L; Ruzicka T
    Agents Actions; 1991 Mar; 32(3-4):339-42. PubMed ID: 1650525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.